Isolated leptomeningeal carcinomatosis (Carcinomatous meningitis) after taxane-induced major remission in patients with advanced breast cancer

Oncology

Volumn 63, Issue 1, 2002, Pages 6-15

  Kosmas, Christos ^a   Malamos, Nikolaos A ^a   Tsavaris, Nikolas B ^b   Stamataki, Melina ^a   Gregoriou, Achilleas ^a   Rokana, Sofia ^a   Vartholomeou, Maria ^a   Antonopoulos, Minas J ^a  

^a HELENA VENIZELOU HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Breast Cancer; Carcinomatous meningitis; Docetaxel; Leptomeningeal carcinomatosis; Paclitaxel

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOXANTRONE; PACLITAXEL; STEROID; TAXANE DERIVATIVE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CARCINOMATOUS MENINGITIS; CONTROLLED STUDY; DATA BASE; FEMALE; HISTOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; MENINGEAL NEOPLASMS; MENINGITIS; METHOTREXATE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; SURVIVAL RATE; TAXOIDS;

EID: 0036362194     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065714     Document Type: Article

References (36)

1. Leptomeningeal metastases: Comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemia
2. Meningeal carcinomatosis
3. Carcinomatous meningitis associated with infiltrating lobular carcinoma of the breast
4. Association of leptomeningeal carcinomatosis in carcinoma of the breast with infiltrating lobular carcinoma
5. Meningeal carcinomatosis in breast cancer
6. Central nervous system metastasis from breast carcinoma. Autopsy study
7. Meningeal carcinomatosis in patients with breast carcinoma
8. Adriamycin and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer
9. Complete remissions in metastatic breast cancer treated with combination drug therapy
10. Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer
11. Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer: A Southwest Oncology Group Study
12. Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients (pts) with node-positive primary breast cancer
13. Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel
14. Adjuvant therapy with 5-fluorouracil, Adriamycin, cyclophosphamide and BCG (FAC-BCG) for state II or III breast cancer
15. Brain metastases in breast cancer patients receiving adjuvant chemotherapy
16. Distribution of 3H-Taxol in the nervous system and organs of rats
17. Carcinomatous meningitis in patients with breast cancer
18. Meningeal carcinomatosis from transitional cell carcinoma of the bladder
19. Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases
20. Chemotherapy-induced complete regression of choroidal metastases and subsequent isolated leptomeningeal carcinomatosis in advanced breast cancer: A case report and literature review
21. Leptomeningeal carcinomatosis, presenting features and prognostic factors
22. Cerebrospinal fluid cytology in patients with cancer, minimizing false-negative results
23. Leptomeningeal carcinomatosis
24. Neuro-imaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis
25. Cytologically negative carcinomatous meningitis: Usefulness of CSF biochemical markers
26. MR imaging of the meninges. II. Neoplastic disease
27. CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer
28. Treatment of leptomeningeal metastases evaluated by interface cytogenetics
29. Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients
30. Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment
31. A randomized controlled trial comparing intrathecal sustained-release cytarabine (Depo-Cyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors
32. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis
33. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis
34. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: Is intrathecal chemotherapy necessary?
35. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel